Patents Etcetera's History, Mission and Business Model
History
Located near Boston, Massachusetts, Patents Etcetera is an intellectual property firm founded in 2006 to provide expert patent filing services to a niche demographic: individual inventors, seed companies, pre- start-ups and small businesses. We provide services that are first, affordable, and second, optimized to the client's IP strategy and aim to solidify the IP portfolio of a small business. Since our inception, we have filed patent applications in areas of drug delivery, drug dosage forms in ophthalmics, dentistry and vaccines, nanotechnology products and novel mechanical device designs. As part of our team, we have scientists and engineers as technical experts advising, consulting and assisting us in these areas.
Mission
Patents Etcetera mission is to help companies and inventors obtain strong patent protection by formulation of claims that are in compliance with US and international statutes and regulations. Additionally, Patents Etcetera experts assist in the management of the myriad details that accompany patent filing.
Our mission as a small intellectual property services firm is to provide high quality, affordable services to our clients. Our goal is to build credibility among our clients by providing the highest quality services in a time-driven manner. We pride ourselves in our efficiency, affordability and timeliness.
Business Model
Our business model is based on building expertise in our firm, by building a network of experts in the various fields of engineering, medicine, biology and chemistry. We draw upon our experts for consultation and technical assistance to provide ourselves with a large breadth of expertise in multi-disciplines. Depending upon the technical area of the invention, Patents Etcetera draws upon its highly trained experts in that field, to perform prior art searches, summarize background work and draft specifications and claims of the patent application. Thus, our applications are focused, detailed, well-written and comprehensible to the patent examiner. Regardless of whether the invention is an improved mouse trap, novel sports product, a drug delivery system or a nanotechnology product, Patents Etcetera has expertise to move patent applications smoothly through the patent application processes of the United States Patent and Trademark Office (USPTO) and the international Patent Cooperation Treaty (PCT).
We do not accept patent projects that we feel are non-patentable.
-
David Karasic, Principal and Founder
Mr. Karasic is a registered patent agent with the USPTO, with 20+ years of work experience in biomedical engineering, electronics and mechanical design, electrical and computer engineering and mechanics. As a principal of Patents Etcetera, Mr. Karasic has filed patent applications on behalf on individual inventors, seed start-up companies and small businesses. He has filed applications in nanotechnology, biomaterials, drug delivery, vaccine delivery, dental applications, ophthalmic drug delivery and mechanical design. Additionally, Mr. Karasic has worked in collaboration with established law entities to assist in their patent-associated needs. Mr. Karasic holds a B.S. in Biology and Chemistry from Trenton State College and a M.S. in Engineering from Boston University.
-
Shikha Barman, Ph.D. Technical Expert and Founder
A seasoned veteran in the drug delivery, biomaterials and pharmaceutics fields, Dr. Barman has over 17 years of experience in drug development, with over 70 publications and 27 issued patents and patent applications. As a founder of the company, Dr. Barman provides Patents Etcetera with technical expertise in chemistry, biomaterials, pharmaceutics and drug delivery for various medical applications. Additionally, Dr. Barman advises Patents Etcetera on IP strategy and portfolio establishment for companies. Dr. Barman holds a B.S. and M.S. from Auburn University, a M.S. in Polymer Chemistry and a dual degree Ph.D. in Plastics Engineering and Polymer Science from the University of Massachusetts.
-
Mary Osbakken, M.D., Ph.D. Clinical Expert and Advisor
Dr. Osbakken is an eminent veteran clinician in the drug development industry and is a consultant to Patents Etcetera on the IP assessment of drugs being developed for the clinic, by seed companies and small businesses. Dr. Osbakken holds M.S. degrees in Physiology and Biomedical Engineering from the University of Illinois and Drexel University, respectively, as well as a Ph.D. in Physiology from Thomas Jefferson University and an M.D. from Temple University. After having been in Academe (cardiology, biochemistry/biophysics, anesthesia, physiology, and magnetic resonance imaging) for 20 years (U PA, Penn State, MGH), Dr. Osbakken has over 16 years of Pharmaceutical Industry Experience, including leadership roles in big Pharma (Bristol Meyers Squibb, Aventis and Sanofi-Aventis), small to mid-sized pharma (Inotek Pharmaceuticals and Somnus Therapeutics), and CROs (Covance) in multiple therapeutic areas. She has been on Scientific Advisory Boards for small academic incubator companies and CROs; and is the author of over 125 basic science and clinical peer reviewed papers and two books on cardiovascular imaging.
-
Arthur J. Coury, Ph.D. Technical Expert and Advisor
Dr. Coury is an eminent biomaterials scientist, with numerous publications and issued patents in the fields of polymer materials, medical devices, biocompatible materials and drug delivery. Art Coury holds a B.S. degree in chemistry from the University of Delaware (1962), a Ph.D. in organic chemistry (1965) and an M.B.A. (1980) from the University of Minnesota. His industrial career includes positions as: Senior Research Chemist at General Mills, Inc. (1965-1976), Director, Polymer Technology and Research Fellow at Medtronic, Inc. (1976-1993), Vice President, Research and Chief Scientific Officer at Focal, Inc. (1993-2000), and Vice President, Biomaterials Research at Genzyme Corporation (2000-June, 2008). He currently is a consultant. He holds over fifty distinct patents and has published and presented widely in his field. His professional service has included: Chair, Minnesota Section, American Chemical Society (1989-1990); President, Society for Biomaterials, USA (1999-2000); President, American Institute for Medical and Biological Engineering (2003-2004) and membership on several university, society and corporate advisory boards. His recent recognitions have included the delivery of distinguished lectureships, receipt of the 2007 Innovation and Technology Development Award of the Society for Biomaterials, being named as one of “100 Notable People in the Medical Device Industry” by MD&DI magazine, 2008, and induction into the National Academy of Engineering, USA, 2009.
Dr. Coury assists Patent Etcetera with IP assessment of patent portfolios in the biomedical engineering, biomaterials and medical device fields.
Our People:
